Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Freeze-dried powder containing ritodrine hydrochloride as well as application and preparation method thereof

A technology of ritodrine hydrochloride and freeze-dried powder, which is applied in the directions of medical preparations containing active ingredients, medical preparations without active ingredients, and freeze-dried transportation, so as to achieve the advantages of expanding production, facilitating transportation and storage, and reducing transportation costs. Effect

Active Publication Date: 2022-06-07
THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no ritodrine hydrochloride freeze-dried powder on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Freeze-dried powder containing ritodrine hydrochloride as well as application and preparation method thereof
  • Freeze-dried powder containing ritodrine hydrochloride as well as application and preparation method thereof
  • Freeze-dried powder containing ritodrine hydrochloride as well as application and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: a kind of ritodrine hydrochloride freeze-dried powder, described component content and preparation technology are as follows:

[0034]

[0035] Preparation Process:

[0036] (1) take by weighing sorbitol, add an appropriate amount of water for injection, stir and dissolve, add tert-butanol and ritodrine hydrochloride successively, stir to dissolve the main drug completely;

[0037] (2) Add activated carbon, stir for more than 10 minutes, decarbonize, and add water for injection to the full amount;

[0038] (3) using citric acid to adjust the pH value to 4.5, and filling with nitrogen for protection;

[0039] (4) filling the medicinal liquid in the ampoule bottle and freeze-drying; the freeze-drying curve is:

[0040] S1 pre-freezing treatment: cool down to -40±5℃, keep for 2-3 hours;

[0041] S2 heating stage: raise the temperature to -20±5°C, and keep the temperature for 2 to 4 hours;

[0042] S3 cooling stage: cool down to -35±5℃, keep warm for 2-...

Embodiment 2

[0046] Embodiment 2: a kind of ritodrine hydrochloride freeze-dried powder, described component content and preparation technology are as follows:

[0047]

[0048] The preparation process is the same as:

[0049] (1) take by weighing sorbitol, add an appropriate amount of water for injection, stir and dissolve, add tert-butanol and ritodrine hydrochloride successively, stir to dissolve the main drug completely;

[0050] (2) Add activated carbon, stir for more than 10 minutes, decarbonize, and add water for injection to the full amount;

[0051] (3) use citric acid to adjust pH value to be 6.0, and fill with nitrogen protection;

[0052] (4) filling the medicinal liquid in the ampoule bottle and freeze-drying; the freeze-drying curve is:

[0053] S1 pre-freezing treatment: cool down to -40±5℃, keep for 2-3 hours;

[0054] S2 heating stage: raise the temperature to -20±5°C, and keep the temperature for 2 to 4 hours;

[0055] S3 cooling stage: cool down to -35±5℃, keep wa...

Embodiment 3

[0059] Embodiment 3: a kind of ritodrine hydrochloride freeze-dried powder, described component content and preparation technology are as follows:

[0060]

[0061]

[0062] Preparation Process:

[0063] (1) take by weighing sorbitol, add an appropriate amount of water for injection, stir and dissolve, add tert-butanol and ritodrine hydrochloride successively, stir to dissolve the main drug completely;

[0064] (2) Add activated carbon, stir for more than 10 minutes, decarbonize, and add water for injection to the full amount;

[0065] (3) use glycine to adjust the pH value to 5.0, and fill with nitrogen for protection;

[0066] (4) filling the medicinal liquid in the ampoule bottle and freeze-drying; the freeze-drying curve is:

[0067] S1 pre-freezing treatment: cool down to -40±5℃, keep for 2-3 hours;

[0068] S2 heating stage: raise the temperature to -20±5°C, and keep the temperature for 2 to 4 hours;

[0069] S3 cooling stage: cool down to -35±5℃, keep warm for 2...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical preparations, and discloses ritodrine hydrochloride-containing freeze-dried powder as well as application and a preparation method thereof, and the ritodrine hydrochloride freeze-dried powder is prepared from ritodrine hydrochloride, sorbitol, tert-butyl alcohol and a pH regulator; the preparation process is simple and comprises the following steps: dissolving sorbitol in water for injection, adding tert-butyl alcohol and ritodrine hydrochloride, replenishing water for injection to full dose, adjusting the pH value, filling into an ampoule, freeze-drying, and pulling and sealing. Detection on the obtained product shows that the ritodrine hydrochloride freeze-dried powder is relatively high in stability, low in content of related substances, low in moisture content, good in appearance and beneficial to long-time transportation and shelf life.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, in particular to a freeze-dried powder of ritodrine hydrochloride and a preparation method thereof. Background technique [0002] Ritodrine hydrochloride is a direct-acting sympathomimetic drug with mainly beta-adrenergic activity and selective action on beta2 receptors (beta2 agonists). Reduces uterine contractility and is used to prevent premature labor. Ritodrine hydrochloride is usually administered by intravenous infusion. Where possible, 5% dextrose should be used as a diluent with the aid of a syringe pump when the concentration should be 3 mg / mL. The recommended initial infusion rate is 50 to 100 pg / min, increasing at 10 to 20-min intervals in 50 pg / min increments until there is evidence of patient response. Maintenance therapy should be maintained at the lowest effective dose, usually about 50 to 100 pg / min. If no syringe pump is available, infusion can be performed using a controll...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/19A61K31/137A61K47/26A61K47/10A61P15/06
CPCA61K9/19A61K31/137A61K47/26A61K47/10A61P15/06Y02A50/30
Inventor 李灵燕陈志敏李秀芳
Owner THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products